Skip to Main Content

Author Details

Iris Chiara Salaroglio
University of Turin
2013
38
20
PMIDPaper TitleJournal TitlePublished Year
36165915Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.Clin Cancer Res2023
37616241Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.J Med Chem2023
37285115Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.Clin Cancer Res2023
36614241Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.Int J Mol Sci2023
35197103SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.J Exp Clin Cancer Res2022
36232858Naked and Decorated Nanoparticles Containing H<sub>2</sub>S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells.Int J Mol Sci2022
35953814Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.J Exp Clin Cancer Res2022
35887313Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models.Int J Mol Sci2022
35214025Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors.Pharmaceutics2022
33423689Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons.J Exp Clin Cancer Res2021
33795785Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.Sci Rep2021
33809114Plant-Derived <i>Trans</i>-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation.Nutrients2021
34955385Impact of cancer metabolism on therapy resistance - Clinical implications.Drug Resist Updat2021
34840068Hypoxia as a driver of resistance to immunotherapy.Drug Resist Updat2021
31107974Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.Int J Cancer2020
31488891Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.Cell Death Differ2020
31285546The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.Cell Death Differ2020
31100351Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?Semin Cell Dev Biol2020
30584838Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells.J Med Chem2019
31265310Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.Mol Pharm2019
31117237ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer.Int J Mol Sci2019
31078776Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.J Thorac Oncol2019
30717376Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution.Pharmaceutics2019
29191785Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors.J Control Release2018
29890725New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro.Molecules2018
30254183Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma.Mol Cancer Ther2018
30423827Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells.Int J Mol Sci2018
30482226Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.J Exp Clin Cancer Res2018
29748013Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.Lung Cancer2018
29399399Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.Oncoimmunology2017
28186465Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment.Nanomedicine (Lond)2017
28499449PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.Mol Cancer2017
27466354Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.Mol Cancer Ther2016
27811376P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors.Oncotarget2016
25544757Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma.Oncotarget2015
23771630Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.Cell Mol Life Sci2014
24896565The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.J Cereb Blood Flow Metab2014
23897632Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.Neuro Oncol2013
  • 1 - 38 of 38

Recommended Authors

Melissa L Abel
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Jin-Ku Lee
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 1
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 0
Isabelle Martins
Universite de Paris, Sorbonne Universite, Inserm U8, Institut Universitaire de France
Career Start Year 2007
Number of shared co-authors 1
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Career Start Year 2004
Number of shared co-authors 0
Stephane Ferretti
Novartis Institutes for BioMedical Research
Career Start Year 2003
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Oscar M Tirado
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Career Start Year 2000
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Beate Rinner
Medical University of Graz
Career Start Year 2000
Number of shared co-authors 0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 2
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 0
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 0
James H Doroshow
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 0
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Chiara Riganti
University of Turin
Co-authored papers 36
Claudia Maria Hattinger
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 2
Manuela Iezzi
Co-authored papers 2
Massimo Serra
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 2
David A Waller
St Bartholomew's Hospital
Co-authored papers 1
Adriana Salcedo
University of Toronto
Co-authored papers 1
Shu-Dong Zhang
Peking University Third Hospital
Co-authored papers 1
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 1
Sara Busacca
University of Leicester, Robert Kilpatrick Clinical Sciences Building
Co-authored papers 1
David A Moore
University College London Cancer Institute
Co-authored papers 1
Qi Zhang
Institute of Hydrobiology, Chinese Academy of Sciences
Co-authored papers 1
Carmen Abate
Polish Academy of Sciences
Co-authored papers 1
Annabel Sharkey
Sheffield Teaching Hospital NHS Trust
Co-authored papers 1
Apostolos Nakas
University Hospitals of Leicester NHS Trust
Co-authored papers 1
Dean A Fennell
University of Leicester
Co-authored papers 1
John Le Quesne
Beatson Cancer Research Institute, University of Glasgow
Co-authored papers 1
Javier De Las Rivas
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Carolyn Jones
University of Cambridge
Co-authored papers 1
Jin-Li Luo
University of Leicester
Co-authored papers 1
Francesco Berardi
Universita degli Studi di Bari
Co-authored papers 1
Kelvin Cain
University of Cambridge
Co-authored papers 1
Alan G Dawson
University Hospitals of Leicester NHS Trust
Co-authored papers 1
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 1
Release 1.2